Hypermorphic mutation of phospholipase C, 2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Liu, T.-M., Woyach, J. A., Zhong, Y., Lozanski, A., Lozanski, G., Dong, S., Strattan, E., Lehman, A., Zhang, X., Jones, J. A., Flynn, J., Andritsos, L. A., Maddocks, K., Jaglowski, S. M., Blum, K. A.,Volume:
126
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2015-02-626846
Date:
July, 2015
File:
PDF, 2.01 MB
english, 2015